# Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer

> **NCT00875849** · PHASE2 · COMPLETED · sponsor: **Centre Antoine Lacassagne** · enrollment: 53 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** cisplatin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00875849
- **Lead sponsor:** Centre Antoine Lacassagne
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-02
- **Final completion:** 2013-12
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875849, "Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00875849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*